https://www.selleckchem.com/pr....oducts/rocaglamide.h
From 2000-2004 to 2010-2014, no improvement in OS was seen for patients treated in the public setting. Survival of patients with malignant pancreatic tumors remains dismal. Socioeconomical variables, especially health care funding, are major determinants of survival. Further work is necessary to decrease inequalities in access to medical care for patients with pancreatic cancer in Brazil.Organotypic skin tissue models have decades of use for basic research applications, the treatment of burns, and for efficacy/safety evaluation stud
Like
Comment
Share
